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Abstract.  The SEC13 gene of Saccharomyces cerevi- 
siae is required in vesicle biogenesis at a step before 
or concurrent with the release of transport vesicles 
from the ER membrane. SEC13 encodes a 33-kD pro- 
tein with sequence homology to a series of conserved 
internal repeat motifs found in/3 subunits of heterotri- 
meric G proteins.  The product of this gene, Secl3p, is 
a cytosolic protein peripherally associated with mem- 
branes.  We developed a cell-free Secl3p-dependent 
vesicle formation reaction. Secl3p-depleted mem- 
branes and cytosol fractions were generated by urea 
treatment of membranes and affinity depletion of a 
Secl3p-dihydrofolate reductase fusion protein, respec- 
tively.  These fractions were unable to support vesicle 
formation from the ER unless cytosol containing 
Secl3p was added. Cytosolic Secl3p fractionated by 
gel filtration as a large complex of about 700 kD. 
Fractions containing the Secl3p complex restored ac- 
tivity to the Secl3p- dependent vesicle formation reac- 
tion. Expression of SEC13 on a multicopy plasmid 
resulted in overproduction of a monomeric form of 
Secl3p, suggesting that another member of the com- 
plex becomes limiting when Secl3p is overproduced. 
Overproduced, monomeric Secl3p was inactive in the 
Secl3p-dependent vesicle formation assay. 
V 
ECTORIAL transport  of newly  synthesized proteins 
from the endoplasmic reticulum to the Golgi appa- 
ratus is achieved by the formation of transport vesi- 
cles from the ER and subsequent transport, targeting and fu- 
sion of vesicles with the Golgi membrane (37). In the yeast 
Saccharomyces cerevisiae, at least  22  genes  required  for 
vesicle-mediated  ER-Golgi  transport  have been  identified 
genetically (8, 26, 28, 30, 31, 34, 43). SEC13 is one of these 
genes, as evidenced by the accumulation of  core-glycosylated 
secretory proteins in sec13 temperature-sensitive mutants at 
the  restrictive  temperature  (33). SEC13 can  be  further 
defined as one of a class of genes required for the formation 
of mature transport vesicles from the ER membrane. At the 
restrictive  temperature,  sec13 cells  accumulate  ER mem- 
brane,  but not the intermediate  vesicles  seen  in mutants 
defective in the later step of vesicle consumption.  Further- 
more,  secl3  interacts  genetically  with  sec12, sec16, and 
sec23, which are also defective in vesicle biogenesis (21). 
A number of SEC gene products have been characterized 
at the molecular level, and the biochemical functions of Sec 
proteins are beginning to be elucidated using in vitro assays 
that reconstitute ER to Golgi transport (2, 3, 39, 52) or the 
subreaction of vesicle formation and release from the ER (6, 
38). The first See protein purified by this assay was the prod- 
uct of the SEC23 gene, which was isolated by biochemical 
complementation of the sec23 temperature-sensitive  cyto- 
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solic defect (16). Sec23p is an 85-kD cytosolic protein that 
co-purifies with a  105-kD protein also required for ER to 
Golgi transport  and is designated  Sec24p (17). A  second 
gene blocked in export from the ER, SEC12, encodes a trans- 
membrane  glycoprotein  resident  in  ER  and Golgi  mem- 
branes  (5, 27). SAR/, initially isolated as a multicopy sup- 
pressor  of the sec12 mutant phenotype,  encodes  a 21-kD 
GTPase with homology to the Ras superfamily of GTPases 
(28) Sarlp recruitment  to membranes  is Secl2p-dependent 
and required  for vesicle formation in vitro (6). 
Because SEC13 is required for vesicle formation in vivo 
and interacts genetically with other SEC genes that have been 
characterized  biochemically,  we undertook the molecular 
and biochemical characterization of  the SEC13 gene product. 
SEC13 encodes a 33-kD cytosolic protein,  peripherally  as- 
sociated with cellular membranes.  The sequence of SEC13 
shares homology, within a series of internal repeats, with a 
number of  proteins including the/5 subunit of  heterotrimeric 
G proteins (7, 12). We developed an in vitro assay for vesicle 
formation and release from the ER that is dependent on the 
addition of cytosolic Secl3p. Using this assay, we show that 
Secl3p is  included  in a large  complex of about  700  kD, 
which is active in promoting vesicle formation in vitro. 
Materials and Methods 
Strains,  Materials,  and General Methods 
Yeast strains used in this study are RSY607  (MATu, ura3-52, leu2-3,112, 
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University Medical School), RSY265 (MATa, secl3-1, ura3.52, his4-619) 
(21), RSY266 (21); (MATa, see13.1, ura3-52, his4-619), RSY637 (MATa/a, 
ura3-52/ura3-52,  leu2-3,H2/leu2-3,112,  sec13::URA3/SEC13), RSY742 
(pNS1353, MATe, ura3-52, leu2-3,H2, secl3::URA3), RSYS12 (pCKI313; 
MATa, leu 2-3, 112), The protease-deticient wild-type strain RSY607 was 
constructed by integrative disruption of the PEP4 gene. Wild-type RSY255 
cells were transformed with an Eeo RI-Xho I fragment of  pTS15 (1), carrying 
the PEP4 gone disrupted by URA3. The pep4 deletion phenotype of  transfor- 
mants was verified by a defect in earboxypeptidase Y maturation detected 
by APNE plate assay (19) and immunoblotting using anti-carboxypeptidase 
Y antibody  (49).  Plasmid  vectors  used were pRS306,  315, or 316 (46), 
where  CEN-containing  or integrating  plasmids  were  required.  Plasmids 
YEp352 and Ylp352 (18) are a high copy number 2~ and integrating plas- 
mid, respectively. Yeast culture, genetic manipulations and molecular tech- 
niques were as described by either Sherman et al. (45) or Sambrook et al. 
(40). Materials were obtained from Sigma Chemical Company (St. Louis, 
MO) unless stated otherwise. 
Gel electrophoresis  was performed  according  to the Laemmli  SDS- 
PAGE method (23), using 12% or 12.5% pelyacrylamide.  Electrophoresed 
proteins were visualized by silver staining (25). Transfer of proteins from 
SDS-PAGE to rtitrocelluiose was performed as described (6, 51). Attinlty- 
purified anti-Secl3p  antibody was used at 1:300 dilution,  affinity purified 
anti-Sec23p antibody (provided by T. Yoshihisa, this laboratory)  at a dilu- 
tion of 1:2,500 and anti-Sarlp antibodies (provided by C. Bariowe, this labo- 
ratory)  at  1:1,500 dilution.  Secondary  antibodies  were  either  goat-anti- 
rabbit IgG, conjugated to HRP (Amersham Corp., Arlington Heights, IL), 
at a dilution of 1:5,000 in TBS, or t2~I-protein A (Amersham Corp.),  at a 
dilution  of  1:2,500.  Filter-bound  antibodies  were  then  detected  by 
peroxidase-catalyzed chemiluminescence (ECL kit, Amersham Corp.),  or 
by  densitometry  using  a  Molecular  Dynamics  (Sunnyvale,  CA)  Phos- 
phorlmager. 
Cloning and Sequence  Determination of  SEC13 
~ld-~  and Mutant Alleles 
The SEC13 gene was isolated from a library of S. cerevisiae ganomic se- 
quences in the multicopy shuttle vector YEpl3 (29). Insert sequences from 
a plasmid that complemented  the temperature  sensitive mutation secl3-1 
were  subeloned  into  the 2tL, URA3 vector YEp352.  The smallest  com- 
plementing  subclone  contained  a  1.9-kb SmaI-SacI  genomic  fragment 
(pCK1313). Deletion derivatives were produced  from the SacI end of the 
fragmem by digestion of linear plasmid DNA with exonuclease 1II and S1 
(15). Using plasmids with different deletion endpoints as the templates, the 
minimum complementing region was sequenced by the Sanger method (41) 
following the protocol  for the Sequenase kit (USB, Cleveland,  OH).  Se- 
queneing of  the complementary strand was performed using synthetic oligo- 
nucleotide primers derived from the sequence of  the first strand. To test for 
linkage between the cloned sequences and the SEC13 locus, a 2.0-kb Sinai 
to HindIl/fragment, cleaved by XbaI was used to direct the integration of 
YIp352 (containing a URA3  marker gene) to the locus of the cloned DNA 
try transformation of RSYT.55 (~, ura3-5  2 , leu2-  3, 112). Two transformants 
were crossed to RSY266 (a, secl3-1, um3-52, his4-619) and 12 tetrads were 
dissected and analyzed for Ts  + and Ura  + phenotypes. 
The sec13 mutations were mapped by marker rescue recombination with 
plasmid-borne SEC13. A sec13 mutant to be mapped was transformed with 
each of the plasmids pCK1313, A5.7, A6.4, A6.1, A7.1, and A8.2 (Fig.  1). 
Because these plasmids carry incomplete copies of SEC13 the transformants 
remain temperature sensitive. To stimulate mitotic recombination, transfor- 
mant cultures were exposed briefly to shortwave UV such that greater than 
50% of the cells survived. Temperature resistant recombinants were scored 
after plating at 37~  Each of the mutant alldes was cloned by transforma- 
tion of the mutant strains with plasmid pCK1313 containing a gap within 
the SECt3 sequences produced by cutting with Mscl (Fig. 2).  Expression 
of the mutam alleles from the high copy number plasmid resulted in less 
severe Ts- phenotypes  when  compared  to strains  carrying  the chromo- 
somal mutant allele. Using this reduced temperature sensitive phenotype as 
a guide, transformants containing the mutant alleles on the plasmid were 
identified. The base changes responsible  for the mutations were obtained 
by sequencing the COOH-terminal third of  the mutant allele on the plasmid 
using  synthetic  oligonucleotide  primers  and the Sanger method,  as de- 
scribed above. 
SEC13 Disruption 
To disrupt  the SECI3 gene,  SmaI-BgllI fragment and ClaI-HindIII  frag- 
ments from SEC13 were inserted in inverted orientation into the integrating 
vector pRS306 (URA3)  to produce pCK1316, pCK1316 was cut with HindlII 
and  transformed  into a diploid  ura3-52, leu2-3,112 strain.  Homologous 
recombination replaced one of the SEC13 alleles with a disrupted  copy of 
the gene. This procedure is referred to as the ~ transformation method for 
gene disruption (46). The heterozygous diploid was sperulated and progeny 
were tested for growth and Ura  + phenotypes. 
Construction of  SEC13:  DHFR Hybrid Plasmids 
and Strains 
To construct a full-length fusion of SEC13 to the mouse dihydrofolate reduc- 
tase (DHFR) l gene, pCK1313, containing the original clone of SEC13 in 
L Abbreviations used in this paper: B88, Buffer 88; B88CB, Buffer 88 col- 
umn buffer; DHFR, dihydrofolate reductase; MSS, medium speed superna- 
tant;  MTX, methotrexate. 
Figure  L  Physical  map  of 
SEC13.  The  plasmid  sub- 
clones of the SEC13 locus in 
the high copy vector YEp352 
are shown with their ability to 
complement the  secl3-1  mu- 
tation.  The  hatched  region 
represents the predicted open 
reading  frame.  The  plasmid 
pCK1316, used for disruption 
of the SEC13 gene, appears in 
the integrated state.  (The size 
of  the  pRS306  plasmid  se- 
quence is not to scale.) 
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51  tttatatcagcatacaaatggtcgtcatagctaatgcgcacaacgaatta  100 
MVVIANAHNEL 
X~I 
I01  atccatgacgctgttctaaactattatgggaagcgccttgcaacctgctc  150 
IHDAVLDYYGKRL  TCS 
BglII 
151  ttctgacaagacaatcaaaatctttgaagtcgaaggagaaacacacaagt  200 
SDKTIKIFEVEGETHKL 
Mscl 
201  taatagacacgttgactaaccacgaaggcccagtttggcgtgttgattgg  250 
IDTLTGHEGPVWRVDW 
251  gcacatcctaaattcggaaccattttggcatcgtgttcttatgatggtaa  300 
AHP  FGTILASCS  DGK 
301  agtgttgatttggaaggaagaaaacggtagatggtctcaaattgccg~tc  350 
VLIWKEENGRWSQIAVH 
351  atgctgtccactctgcttctgtcaactctgttcaatgggctcctcatgaa  400 
AVHSASVNS  QWAPHE 
401  tatggccccctactgctggttgcttcctctgatggtaaggtctccgtagt  450 
YGPLLLVASSDGKVSVV 
Clal 
451  agagttcaaagaaaacggtactacttccccaataatcatcaatgctcatg  500 
EFKENGTTSPIIIDAHA 
501  ccattggcgttaactctgcttcttgggcsccagctaccatcgaagaagat  550 
IGVNSASWA  AT  EED 
551  ggtgaacacaacggtactaaagaatctcgcaagtttgttactgggggtgc  600 
GEHNGTKESRKFVTGGA 
601  tgacaatttggtaaagatttggaagtacaattcagatgcccaaacttatg  650 
DNLVKIWKYNSDAQTYV 
651  ~tctggaaagcaccttagaaggtcacaffcgattgggttagagacgtagca  700 
LESTLE  HS  WVRDVA 
MscI 
701  tggtcacctactgttcttctacgttcttatttooccagtgtttctcaaga  750 
WSPTVLLRSYLASVSQD 
751  tcgcacctgtattatttggactcaagacaatgaacaaggcccatggaaaa  800 
RTCIIWTQDNEQGPWKK 
801  aaactttattaaaagaagaaaaattcccagatgttttatggagagccagt  850 
TLLKEE  FP  VLWRAS 
851  tggtctttgtcaggtaatgtactagctctttccggtggcgataataaagt  900 
WSLSGNVLALSGGDNKV 
901  tactttatggaaggaaaatcttgagggtaaatgggaacccgctggtgaag  950 
TLWKEN  EGKWEPAGE 
951  ttcatcagtgaagagtatcaagaatttaaaatgaaacatctcaaaagaaa  I000 
HQ  * 
I001  aaagaatgc 
Figure 2.  The sequence of the ~3 gene. ~e  predict~ amino 
acid sequence is sh~n  in sin~e-leRer c~e.  ~stfiction sites rele- 
vant to ex~fimen~ ~ed  in ~s  ~r  are ~derlin~.  These 
sequence data are av~lable from EMBL u~er  ae~ssion humor 
LO5929. 
YEp352  (URA3, 2/~) was  digested  with  exonueleaseHl  (15) to  yield 
pNS1339. This plasmid contains the entire coding region of SEC13 with the 
stop codon replaced by polylinker sequences of the vector. A HindlIl frag- 
ment containing the entire coding region of mouse DHFR from pRFY2 
(generously provided by Martin Eilers, Biozentrum, Basel) was subeloned 
into a HindlII site in the polylinker 3' of SEC13 in pNS1339  to generate 
pNS1350. This plasmid encodes a hybrid protein containing the entire cod- 
ing region of SEC13 fused to the entire coding region of DHFR connected 
by  a  9-amino acid  linker with the  following  sequence:  ACKLGGSGI 
(single-letter code).  The SEC13:DHFR fusion was subcloned as an EcoRI- 
HindllI fragment into YEp351 (LEU2, 2t~) to generate pNS1353. Two low 
copy number vectors containing the fusion gene were generated to test the 
ability of the hybrid protein to complement a temperature sensitive see13 
allele and the see13  null allele. The EcoR/-HindIII fragment containing the 
SEC13:DHFR fusion was  subcloned  into pRS316  (CEN6, URA3) and 
pRS315 (CEN6, LEU2) to generate pNS1351 and pNS1352,  respectively. 
To test whether the hybrid protein could restore SEC13 function to a 
strain carrying the secl3-1 temperature sensitive mutations, RSY265 (secl3-1, 
ura3-52, his4-619) was  transformed with pNSI350  (2#,  SEC13:DHFR, 
URA3) or pNS1351  (CEN6, SEC13:DHFR, URA3). Ura  + transformants 
were tested for growth at both 30~  and 37*(2. The ability of SEC13:DHFR 
to complement a null allele of SEC13 was tested by transforming RSY637 
(MATa/ot, ura 3-52/ura3-52, leu2-3,112/leu2-3,112,  secl3::URA3/SEC13) 
with pNS1352  (CEN6~ SEC13:DHFR, LEU2) or pNS1353  (2t~, SEC13: 
DHFR, LEU2). Leu  + transformants were sporulated and Leu  + Ura  + spores 
were tested for growth at both 30 and 37"C. Transformants of RSY637 with 
pNS1353 were sporulated and Ura  +, Leu  + spores selected to yield RSY742 
(pN51353,  MA/-~, ura3-52, 1eu2-3,112, sec13::URA3). 
Preparation of  Antibodies to the Sec13 Protein 
Secl3p antiserum was  elicited against a  hybrid protein composed of a 
COOH-terminal domain of Seel3p fused to Staphylococcal  protein A. A 
BglH-SacI  fragment containing the COOH-terminal 263 amino acids of 
SEC13 was inserted into the protein A fusion vector pRIT32 02). Hybrid 
protein was prepared from E. coil extracts and antibody to this protein pro- 
duced in rabbits, as previously described (13).  Antiserum was  affinity 
purified using a fl-galaetosidase-Secl3p  hybrid protein constructed by fus- 
ing the same BgllI-Sacl fragment of SEC13 to the lacZ gene in the pEX2 
vector (48)￿9 The hybrid protein was isolated and used for affinity purifica- 
tion of the antibody as described (13). 
Yeast Cell Fractionation 
W'rid-type cells and cells expressing SEC13  from a multicopy plasmid were 
grown to exponential phase in YPD (2 % yeast extract, 1% peptone, 2 % glu- 
cose).  A culture of 100 rnl containing ,~2 x  109 cells was transferred by 
centrifugation to 50 ml of 0.1 M Tris sulfate, pH 9.4, 28 mM/3-mercapto- 
ethanol and incubated at 25~  for 10 min. The cells were then transferred 
to 10 ml of spheroplasting buffer (2% yeast extract, 1% peptone, 0.7 M sor- 
bitol, 10 mM "Iris, pH 8.0) and 3,700 units of lyticase (44) were added. Af- 
ter incubation at 30~  for 60 rain, spheroplasts were diluted into 100 ml 
of YPD containing 0.7 M sorbitol as an osmotic support and then incubated 
at 30*C for 60 min with gentle shaking, to regenerate spheroplast metabolic 
activity. The culture was chilled to 4"C, washed with 0.7 M sorbitol, 0.1 M 
NaCI,  10 mM Tris,  pH 8.0, 5 mM MgC12, and stored as a cell pellet at 
-70~  Acid-washed glass beads (0.3 gin) and 0.5 ml of lysis buffer (20 mM 
MES, pH 6.5, 0.1 M NaCl, 5 mM MgCI2, 1 mM PMSE 1/~g/ml pepstatin 
A, and 1/Lg/ml leupeptin) were added to the pallet. Cells were lysed by vor- 
tex mixing at high speed for 30 s, four times. This treatment resulted in es- 
sentially complete cell lysis as judged by light microscopy  of the extract. 
The extract was exposed to different chemical treatments by mixture of 0.1 
mi of extract with an equal volume of lysis buffer containing the reagent. 
Final reagent concentrations were 1% Triton X-100, 2.5 M urea, 0.1 M so- 
dium carbonate (pH 11.5), 0.5 M NaC1. Incubations were continued for 60 
rain on ice then the extracts were separated into soluble and particulate frac- 
tions by eentrifugetion at 100,000  ￿  g for 30 min at 4"C in the ultracen- 
trifuge (Beckman Instruments, Palo Alto, CA). Pellets were dissolved in 
250 td of sample buffer (80 mM Tris, pH 6.8, 2% SDS, 0.1 M DTT, 10% 
glycerol, and 0.01% bromphenol blue) and 50/~1 of a fivefold concentrate 
of sample buffer  was added to the supcrnatant fractions.  Samples  were 
heated to 95"C for 3 rain, further diluted threefold  in Laemmli sample 
buffer, resolved on a 12 % polyacrylamide  gel, transferred to nitrocellulose, 
incubated with anti-Secl3p antibody, and visualized by chemiluminescence, 
as described above. 
Preparation of  Membrane and Cytosol b~actions 
Microsomes were prepared from osmotically lysed  RSY607 cells using 
methods described previously  (3). 
Cytosois were  prepared by liquid nitrogen lysis (9,  47) of RSY607, 
RSY742,  or RSYS12. Cells were grown to 10 OD~oo U/ml, washed twice 
with distilled water,  resuspended as a  thick paste (1,500-2,000 OD6o0 
units/ml) in Buffer  88 (B88;  150 mM KOAc, 250 mM sorbitol, 5 mM 
MgOAc, 20 mM Hepes,  pH 6.8), and frozen as drops in liquid nitrogen. 
Frozen cells were lysed in the presence of liquid nitrogen in a l-liter stainless 
steel blender (Waring, New Hartford, CT) by blending at high speed for 
10 rnin. As the lysate thawed,  B88 containing protease inhibitor mix (0.5 
mM PMSE  1 #g/ml leupeptin,  1 /zg/ml pepstatin A) was added at the 
proportion of 1 ml B88 per g cells.  The lysate was clarified at 18,000 g in 
a Sorvall (Du Pont, Wilmington, DE) SS-34 rotor (12,000 RIM, 15 rain). 
The supernatant from this centrifugntion was clarified further at 150,000 
￿  g in a Beckman 45"13 rotor (40,000 rpm, 60 rain), frozen in liquid nitro- 
gen, and stored at -80oC. Before use, cytosol fractions were thawed and 
clarified  at 300,000  g (90000 rpm, 60 rain, Beckman TLA-100.3 rotor). 
Glycerol, DTT, ATP, and GTP were added so that the final cytosol prepara- 
tion was suspended in B88 column buffer (B88CB; B88 containing 10% 
glycerol, protease inhibitor  mix, 0.5 mM D-IT, 0.25 mM ATE and 0.25 mM 
GTP). 
To  prepare  a  Secl  3p-enriched  cytosol  fraction,  powdered ammonium sul- 
fate  was added gradually, to a final concentration of 30%, to cytosol (pre- 
pared by liquid nitrogen lysis of RSY607 cells and clarified at 300,000  ￿ 
Pryer el al. Secl3p Complex in Vesicle Formation  867 g), and stirred, on ice,  for 30 min. Precipitated protein was collected by 
centrifugation at 17,000 g (12,000 rpm, 15 rain, Sorvail SS-34 rotor) and 
resuspended  in a minimal volume of B88 to a final concentration of 5-10 
mg/ml. 
Methotrexate-Agarose Column Chromatography 
Methotrexate  coupled  to agarose  beads (MTX-agarose),  was poured as a 
1-mi column and washed with B88. Before the first use, nonspecific binding 
sites were  blocked by circulating  60 nag wild-type cytosol  through the 
column, and then washing extensively (>20 column volumes) with B88 con- 
taining 10% glycerol.  RSY742 cytosol (150 rag) was applied to the MTX- 
agarose  column at a  flow rate of 4 ml/h. The flow-through fraction was 
"chased  ~ with I ml of B88CB, collected, and frozen in liquid nitrogen. The 
column was then washed with 10 column volumes of BSgCB containing 
t  M KCI at a flow rate of 10 mi/h. The collected KC1 efuate was dialyzed 
2 h against B88CB, and concentrated to one-half  the original volume using 
a Centriprep-lO device (Amicon, Danvers,  MA), centrifuged at 5,000 rpm 
in a Sorvall GSA rotor.  The MTX-agarose  column was washed with 10 
column volumes  of B88CB.  Proteins bound specifically  to MTX were 
eluted by applying 1.5 column volumes of B88CB containing 50 mM MTX 
(adjusted  to pH 7). After incubating 1-3 h, the column was eluted at 10 
ml/min and washed with 10 column volumes of B88CB containing 0.5 mM 
MTX. All fractions were frozen in liquid nitrogen and stored at -80~ 
The MTX-agarose column was stripped and regenerated before the next 
use by washing with 5 column volumes urea wash (2 M urea, 0.2 M NaCI, 
1% Triton X-100, 0.1 M Tris-HC1, pH 7.5, 2 mM NAN3), followed by ex- 
tensive washing with B88, incubation with B88 containing 50 mM MTX 
for 12 h, and further washing with B88. 
Gel Iqltration of Cytosol 
Cytosol for gel filtration chromatography was prepared by liquid nitrogen 
lysis, as described above. Cytosol (0.5 nil) was applied to a 21-ml Superose 
6  FPLC  column  (Pharmacia  LKB  Biotechnolngy,  Piscataway,  NJ), 
equilibrated in B88CB. The column was run at a flow rate of 0.25 ml/min 
and fractions of 0.5 mi were collected.  The protein concentration of frac- 
tions was determined by the modified Lowry method (42). Fractions were 
analyzed  for Secl3p abundance by immunoblotting using affinity-purified 
anti-Secl3p antibody followed by t2~I-protein A, as described above. Vesi- 
cle formation activity of column fractions from RSY607 cytosol was assayed 
by adding 25/xg protein per 50 #1 reaction from alternating fractions across 
the included volume of the column to the vesicle formation assay, substitut- 
ing purified Sarlp and a high salt DEAE eluate for the KC1 eluate (see be- 
low). Activity of fractions from gel filtration of RSY812 cytosol was deter- 
mined by adding 10 ~tl of each even numbered fraction (10-15 #g protein) 
to the same assa): 
Vesicle Formation Assay 
A Sec13p-dependent  assay for vesicle formation and release from the ER 
was developed by adapting a two-stage reaction that uses an ER-enfiehed 
membrane fraction from yeast (6, 52). The first stage reconstitutes  translo- 
cation of asS-labeled pre-pro-u factor into ER-enriched microsomes and is 
marked by core glycosylation  of pro-~ factor, Each translocation reaction 
contained 2.5/~g membranes, 1.5 t~135S-pre-pro-t~  factor,  1 mM ATE and 
an ATP-regenerating system consisting of 40 raM creatine phosphate and 
0.2 mg/ml creatine phosphokinase.  Translocation reactions were adjusted 
to 12/zl each with B88, and incubated 30 rain at 10*C. After translocation, 
Secl3p was extracted from membranes by adding an equal volume of 5 M 
urea in B88 and incubating on ice for 30-45 rain. Extracted membranes 
were washed twice with 2 ml B88, each followed by centrifugation for 10 
rain at 25,000 g (in 1.5-mi Eppendorf tubes, 15 K rpm, SS-34 rotor) and 
resustmnded  in B88. 
The second stage of the assay permits the cytosol- and ATP-dependent 
release of pretense-protected  35S-pro-~ factor into a supernatant fraction 
separated  from ER by differential centrifugation.  In the second stage,  2.5 
/~g microsomes were combined with Secl3p-depleted cytosol provided by 
one of two mixtures. The first type of Seel3p-depleted eytosol was a mixture 
of flow-throngh and KCI eluate fractions of RSY742 cytosol fractionated on 
MTX-agarose,  as described above. The MTX flow through and KCl eluate 
were combined in a ratio reflecting the proportion of each fraction in the 
original eytosol (about a 10:1 ratio of flow-throngh: eluate), and 200/~g was 
used in each reaction. We later found that the KC1 eluate fraction could be 
replaced with 0.5/~g purified Sarlp (3a) and 7 t~g of a high-salt  DEAE eluate 
(kindly provided by M. Hosobuchi, this laboratory). The high-sait DEAE 
eluate was prepared by applying wild-type cytosol (1.7 g; prepared by liquid 
nitrogen lysis and clarified at 100,000 g) to a 90-ml DEAE Sepharose FF 
column (Pharmacia LKB Biotechnology)  equilibrated in B88 containing 
10% glycerol, 0.5 M KOAc, and 0.5 mM PMSE The column was washed 
with this buffer until the protein concentration, measured as absorbance at 
280 nm, was zero. The column was then washed with B88 containing 10% 
glycerol, 0.75 M KOAc, and 0.5 mM PMSF, and fractions of 8 mi were col- 
lected.  The protein concentration of each fraction was measured by the 
Bradford assay (Bio-Rad,  Richmond, CA), and fractions containing more 
than 0.75 mg/ml protein were combined and dialyzed against 2 liters orB88 
containing 10% glycerol and 0.5 rnM PMSE The dialyzed eluate was con- 
centrated twofold by dehydration in dry Aquacide I (Calbiochem-Novabio- 
chem Corp.,  LaJolla,  CA) and frozen in liquid nitrogen.  The high-salt 
DEAE eluate is enriched in Sec23p and Sec24p (17), but devoid of Secl3p, 
which does not bind to DEAE Sepharose in 0.5 M KOAc. In the reaction 
using purified Sarlp and the high-salt DEAE eluate, 100 t~g of MTX flow- 
through fraction was used. 
Reactions also contained 50 mM GDP-mannose,  0.2 mM GTP, 1 mM 
ATE and an ATP-regenerating system consisting of 40 mM creatine phos- 
phate and 0.2 mg/ml creatine phosphokinase.  The total reaction volume was 
adjusted to 50 #1 by adding B88. Conditions were adjusted so that the addi- 
tion of unfractionated cytosol fell within the linear range of the assay. Reac- 
tions were incubated 30 rain at 30"C and terminated by transfer to ice. An 
aliquot of total reaction mixture was held on ice while the remaining reac- 
tions were centrifuged at 25,000 g (15,000 rpm, Sorvall SS-34 rotor, 10 rain) 
to generate the medium speed supernatant (MSS) fractions.  The total and 
MSS fractions were each treated on ice for 15 min with 0.3 mg/mi trypsin, 
followed by soybean trypsin inhibitor (1.2 rag/rot  for 10 min). Pretense- 
treated reactions were solubilized by adding SDS to 1% and heating at 95~ 
for 5 rain. Core-glycosylated  35S-pro-or factor was quantified in the total 
and MSS fractions by precipitation with concanavalin A (ConA)-Sepharose, 
as described (2). The efficiency of vesicle formation was expressed as the 
percentage of protease protected ConA-precipitable radioactivity (epm) in 
the  MSS  relative to  pretense-protected  ConA-precipitable radioactivity 
(clam) in the total fraction.  The efficiency of vesicle formation in a reaction 
using extracted membranes and unfractionated (Secl3p-containing) cytosol 
was 25-30%. 
Results 
Cloning and Sequencing of the SEC13 Gene 
The SEC13  gene was isolated by screening a genomic library 
of S. cerevisiae in YEpl3 for complementation of the tem- 
perature sensitive growth defect of sec134. A complement- 
ing plasmid was subcloned and a 2.0-kbp HindlII to SmaI 
fragment that on a centromere plasmid complemented the 
sec13-1 mutation was identified. To test whether this frag- 
ment contained the authentic SEC13 gene, the fragment was 
inserted  into the nonreplicating plasmid  YIp352  and was 
directed to integrate into the homologous chromosomal lo- 
cus in S.  cerevisiae by cleavage within the insert sequence 
before to transformation. Transformants were crossed with 
sec134 cells and sporulated.  12 tetrads were dissected and 
each dissection resulted in two Ts§  + and two Ts-,Ura- 
spore clones showing linkage of the integrated plasmid se- 
quences to the SEC13 locus. 
The SEC13 locus was defined further within the HindlII- 
Sinai fragment by subcloning and deletion analysis to iden- 
tify the minimal fragment necessary for complementation of 
the "Is- growth defect (Fig.  1). The DNA sequence of this 
segment revealed a single open reading frame encoding 297 
amino acid residues  (Fig. 2) and predicting  a hydrophilic 
protein with a molecular weight of 33 kD. The peptide se- 
quence of SEC13 was used to search the PIR protein data 
base using the FASTA algorithm and no significant similari- 
ties to known proteins were found. However, examination of 
the SEC13 sequence revealed an internal repeated structure 
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sequence is displayed to align the internal repeated sequence ele- 
ments. The consensus derived from this alignment is compared to 
a consensus sequence derived from a number of  proteins related to 
the/~ subunit of  transducin (7). The positions of  the amino acid sub- 
stitutions  in SEC13  are shown  relative  to this alignment. The sec13-1 
mutation is in the second to last repeated element, and the sec13-4 
and secl3-5 mutations are in the last element. 
(Fig. 3). This same peptide motif is tandemly repeated in a 
number of different proteins, the best known of which is the 
~/subunit of transducin (10, 12).  Other proteins containing 
this repeated motif are divergent in function and thus, the 
structural or functional significance of the repeated motif  is 
not yet dear. 
Mapping and Sequencing of secl3 Alleles 
To investigate the relationship between the repeated peptide 
motif and the function of SEC13, the mutations responsible 
for the four temperature-sensitive alleles of SEC13  were 
identified. The alleles sec13-1, sec13-3, and sec13-4 were ob- 
tained by nitrous acid mutagenesis (34) and secl3-5 was ob- 
tained by UV mutagenesis (Wuestehube, L., personal com- 
munication),  sec134,  sec13-3, and  sec13-5  are  the  most 
restrictive alleles and do not permit growth above 30~  The 
sec13-4 allele is less restrictive and will allow growth at tem- 
peratures up to 34~  Each of the mutations was mapped by 
marker rescue (11), evaluating the ability of a set of plasmids 
containing noncomplementing fragments of the SEC13 gene 
to recombine with a given chromosomal sec13 mutation to 
produce a wild-type phenotype, sec13-1 and sec13-3 recom- 
bined with pCK1314 and A5.7 (Fig. 1) but not with the other 
deletions. Mutations in sec13-4 and sec13-5 recombined with 
pCK1314 but not with the COOH-terminal deletion plas- 
raids. Thus, these mutations map to the most distal COOH- 
terminal segment. The mutant alleles were recovered from 
the chromosome by repair of  gapped plasmid sequences with 
chromosomal information (36).  The sequence of the muta- 
tion bearing plasmids revealed a single base substitution cor- 
responding to each mutant allele: seal3-1 and sec13-3 have 
the same G-to-A change at position 738 changing Ser (224) 
to Lys (these mutants are probably siblings because they 
were obtained from the same mutagenized culture), sec13-4 
has a G-to-A change at position 864 changing Gly(266) to 
Asp, and secl3-5 has a T-to-A change at position 851 chang- 
ing Trp (262) to Arg. These three mutations alter conserved 
positions of the repeated motif emphasizing the importance 
of these amino acid sequence dements for SEC13 function 
(Fig.  3). 
SEC13 Null Is Inviable 
The existence of recessive temperature sensitive alleles of 
SEC13 implies that this gene is essential. The remaining pos- 
sibility that SEC13 was required for growth only at high tem- 
perature was eliminated by the demonstration that a disrup- 
tion allele of SEC13 was inviable at 24~  A 320-bp fragment 
(BgllI-ClaI)  internal  to  the  SEC13  coding  sequence  was 
replaced with the nonreplieating plasmid pRS306 to gener- 
ate pCK1316  (Fig.  1). The SEC13 locus was replaced with 
this disruption allele by the V-transformation method, select- 
ing for Ura  § transformants of a ura3-52 diploid (46).  Upon 
sporulation, the transformed diploids carrying a disrupted 
allele of SEC13 gave rise to two viable Ura- spore clones 
and spores that remained as single cells at 240C (20 tetrads 
dissected).  SEC13  is  therefore  required  for  germination 
and/or growth at 24~ 
Secl3p Is a Peripheral Membrane Protein 
Antibodies reactive with Secl3p were produced using a hy- 
brid protein composed of Staphylococcus protein A fused to 
most of Secl3p. This serum was affinity  purified using a hy- 
brid protein encoded by a fusion of the same segment of the 
SECI3 gene linked to E.  coil LacZ. On immunoblots, the 
purified antibodies recognized a prominent band with the ex- 
pected apparent molecular weight of ,x,33 kD (Fig. 4, lane 
4). This protein band was of greater intensity in extracts of 
cells carrying the SEC13 gene on the high copy number plas- 
mid (pCK1313)  showing that the 33-kD band was indeed the 
SEC13 gene product (Fig. 4, lane/). 
Sec13p behaved as a peripheral membrane protein in cell 
fractionation studies. In wild-type cells, most Sec13p sedi- 
mented in a particulate fraction (Fig. 4, lanes 5 and 6). Treat- 
ment of the extract with the nonionic detergent Triton X-IO0 
released most of the Sec13p into the soluble fraction (Fig. 
4,  lanes  7  and  8)  suggesting that,  in untreated extracts, 
Secl3p partitions into the particulate fraction by association 
with intracellular membranes. Some of the Secl3p was also 
released into the soluble fraction by agents that disrupt pro- 
tein interactions.  Treatment of the extract with carbonate 
buffer, pH  11.5, released most of Sec13p  into the soluble 
fraction (Fig. 4, lanes 9 and 10) and either 2.5 M urea or 
0.5 M NaC1 solubilized some of the protein (Fig. 4, lanes 
11-14). These data indicate that Sec13p  is not an integral 
membrane  protein.  Given that Sec13p  has  no  signal  se- 
quence, we infer that it is a cytosolic, peripheral membrane 
protein. In extracts from cells overproducing Sec13p, much 
of the excess protein was in the soluble rather than particu- 
late fraction suggesting that the putative membrane associa- 
tion sites for Sec13p are saturated by overproduction of the 
SEC13 gene product (Fig. 4, lanes 2  and 3). 
A~inity Depletion of  a Sec13p-Dihydrofolate Reductase 
Hybrid Protein 
To study the role of Secl3p in vesicle formation, we wished 
to develop a Secl 3p-dependent in vitro reaction reconstitut- 
ing vesicle  formation and release  from the ER.  One ap- 
proach that was developed for the assay of Sec23p relied on 
biochemical complementation of sec23-1 mutant membrane 
and cytosolic components incubated at a restrictive tempera- 
ture (16). A similar approach using see13 mutant membranes 
and/or cytosol was unsuccessful: secl3 mutant components 
were no more thermolabile than wild-type components. We 
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distribution of Sec13p. Cell 
lysates were divided into su- 
pematant  (S)  and pellet (P) 
fractions after centrifugation 
at 100,000 g. (Lanes 1-3) To- 
tal lysate and fractions of a 
strain carrying the high copy 
SEC13  plasmid  pCK1313. 
(Lanes 4-14) Total lysate and 
fractions  from  a  wild-type 
strain.  Extracts were treated 
before centrifugation with ei- 
tiler 1% Triton X-100, 0.1 M 
sodium carbonate (pH 11.5), 2.5 M urea, or 0.5 M NaCI. Proteins were resolved by SDS-PAGE, and immunoblot analysis was performed 
using affinity purified anti-Secl3p antibody and chemiluminescence detection. 
then developed an alternative approach involving the physi- 
cal depletion of Secl3p from membrane and cytosol frac- 
tions. Secl3p was extracted from membranes by treatment 
with urea, and removed from cytosol by affinity depletion of 
a Secl3p-DHFR fusion protein. 
SEC13 was fused to the mouse dihydrofolate reductase 
(DHFR) gene to exploit the high-affinity binding of DHFR 
protein to  an inhibitor,  methotrexate (14,  22).  A  SEC13: 
DHFR fusion was constructed by subcloning the entire cod- 
ing region of mouse DHFR into a plasmid containing SEC13 
lacking only the stop codon. This SEC13:DHFR fusion con- 
tained on either a high copy number plasmid (pNS1352)  or 
a centromere-containing,  low copy number plasmid (pNS1353) 
complemented the temperature-sensitive growth defect of 
sec13-1 at 37~  To test whether the SEC13:DHFR fusion was 
able to complement a secl3 null defect, diploid strain RSY 
637,  heterozygous for a  SEC13 disruption (MAT oda, ura 
3-52/ura3-52,  leu2-3,112/leu2-3,112, sec13::URA3/SEC13) 
was transformed with pNS1352  or pNS1353.  Upon sporula- 
tion, viable,  SEC13:DHFR-containing (Ura  +)  spores were 
obtained only from the diploid transformed with the high 
copy  number  plasmid.  The  strain  RSY742  (pNS1353, 
MATot,  ura3-52,  leu2-3,112,  sec13::URA3),  was  isolated 
from these progeny and expressed Secl3p only in the form 
of a  Secl3p-DHFR hybrid,  as described below.  RSY742 
cells grew best at temperatures from 24 to 34~  but grew 
slowly at 37~ 
SDS-PAGE and immunoblot analysis of a cell lysate from 
RSY742  cells using affinity-purified anti-Secl3p  antibody 
detected the presence of a single Secl 3p-reactive species that 
migrated more slowly than native Secl3p (not shown). This 
protein of approximately 55 kD is the size expected for a hy- 
brid protein of Secl3p (33 kD) with DHFR (21.6 kD). Cyto- 
sol (300,000 g supernatant fraction) prepared from RSY742 
cells and fractionated on a gel filtration column revealed a 
high molecular weight complex containing Secl3p-DHFR 
and an abundant monomeric form of Secl3p-DHIFR. A simi- 
lar distribution was seen with cytosol from a strain carrying 
SEC13 on a 2# plasmid (see Fig. 7 b below). 
To remove cytosolic Secl3p from other proteins, a 300,000 g 
supernatant prepared from RSY742 cells was applied to a 
column of methotrexate coupled to agarose (MTX-agarose). 
The majority of protein (70-75%)  did not bind to MTX- 
agarose, but instead appeared in the column flow-through 
(Fig.  5  a,  lane  2),  Additional proteins  that  were  bound 
nonspecifically to MTX-agarose were eluted by washing the 
column with B88 containing 1M KCL (Fig. 5 a, lane 3). This 
treatment released an additional 12-20 % of the total applied 
protein. After a wash with B88 alone (Fig. 5 a, lane 4), the 
remaining proteins bound to MTX-agarose were eluted by 
competition with a 10-fold molar excess of MTX (Fig. 5 a, 
lane 5) followed by a wash with a low concentration of MTX 
(Fig. 5 a, lane 6).  The MTX-eluted material contains one 
abundant protein of approximately 55 kD, and a number of 
less-abundant proteins. In a parallel MTX-agarose column 
fractionation of wild-type cytosol, this abundant protein was 
not seen in the MTX eluate (not shown). 
Immunoblot  analysis  of  Secl3p  distribution  in  MTX- 
agarose column fractions is  shown in Fig.  5  b  (RSY742 
cytosol) and Fig. 5 c (RSY607 cytosol). Secl3p-DHFR was 
not detected in the flow-through fraction (Fig. 5 b, lane 2) 
and trace amounts were present in the KC1 eluate (Fig. 5 b, 
lane 3).  The majority of Secl3p-DHFR was eluted from 
MTX-agarose by competition with excess MTX (Fig. 5 b, 
lane 5). A parallel MTX-agarose fractionation of wild-type 
cytosol is shown in Fig. 5 c. Native Secl3p did not bind to 
MTX-agarose, appearing entirely in the flow-through frac- 
tion (Fig. 5 b,  lane 2). 
The distribution of two additional proteins known to be re- 
quired for vesicle formation in vitro also were determined by 
immunoblotting. Sec23p appeared to bind tightly to MTX- 
agarose, and was not detected in the flow-through (Fig. 5 b, 
lane 2). Sec23p was partially eluted by 1 M KC1 (Fig. 5 b, 
lane 4),  but a portion remained bound and was eluted by 
MTX (Fig. 5 b, lanes 5 and 6). The distribution of Sec23p 
was  similar  in  wild-type  cytosol  fractionated by  MTX- 
agarose (Fig.  5  c).  However,  more Sec23p was eluted by 
MTX  treatment  in  the  Secl3p-DHFR-containing  cytosol 
than in wild-type cytosol (Fig. 5, b and c). Sarlp also bound 
to MTX-agarose (Fig.  5 b  and c),  and the great majority 
eluted with the KC1 wash in both wild-type and Secl3p- 
DHFR cytosol. As for Sec23p,  a small amount of Sarlp was 
tightly bound to MTX-agarose in the Secl 3p-DHFR cytosol, 
eluting with MTX treatment (Fig. 5 b). The partial retention 
of Sec23p and Sarlp by MTX-agarose in the presence of the 
Secl3p-DHFR hybrid protein might reflect interactions be- 
tween these proteins. 
Secl3p-Dependent Vesicle Formation Reaction 
Vesicle  formation and release from an ER-em'iched mem- 
brane fraction has been reconstituted in a two stage reaction 
The Journal  of Cell Biology,  Volume 120, 1993  870 Figure 5. Methotrexate-agarose  chromatography of RSY742 (Secl3p-DHFR) cytosol and wild-type cytosol. (a) RSY742 cytosol applied 
to a column of MTX-agarose. The column flow-through  was collected (lane 2), and the column was washed with 1 M KCI in B88CB (lane 
3). Following  a B88CB wash (lane 4), bound proteins were eluted by 50 mM MTX in B88CB (lane 5) and washed through the column 
with 5 mM MTX in B88CB (lane 6). Protein fractions were resolved by SDS-PAGE (10 #ghane) and visualized by silver staining. Mr 
marker values are given in kD. (b) Immunoblot  analysis of Secl3p-DHFR, Sec23p, and Sarlp distributions in fractions from MTX-agarose 
fractionafion of RSY742 (expressing Secl3p-DHFR) cytosol: lane 1, cytosol; lane 2, flow  through; lane 3, 1 M KCI eluate; lane 4, B88 
wash; lane 5, 50 mM MTX eluate; lane 6, 5 mM MTX "chaseY  Fractions were resolved by SDS-PAGE (10/zg/lane), and immunoblot 
analysis was performed and developed  by chemiluminescence.  (c) Immunoblot analysis of Secl3p, Sec23p, and Sarlp distributions in frac- 
tions from MTX-agarose fractionation of RSY607 cytosol: lane 1, eytosol; lane 2, flow  through; lane 3, B88 wash; lane 4, 1 M KC1 eluate; 
lane 5, B88 wash; lane 6, 50 mM MTX eluate. Note that the RSY607 column had an additional B88 wash and that the 5 mM MTX "chase" 
is not shown  because no protein was detected in this fraction. Protein fractions were resolved by SDS-PAGE, immtmoblot analysis was 
performed, and developed by chemiluminescence. 
using unextracted membranes and cytosol (6),  In the first 
stage, 35S-labeled pre-pro-c~ factor was translocated into an 
ER-enriched membrane fraction to serve as a secretory pro- 
tein marker (2, 20). Translocation into the ER was marked 
by the addition of core oligosaccharides to 35S-pro-a factor. 
In the second stage, cytosol and ATP were added to mem- 
branes and the reaction was incubated at 30~  Under these 
conditions, protease-protected, core glycosylated 35S-pro-c~ 
factor was released as a  slowly sedimenting compartment 
separable from the ER by differential centrifugation. 
Sec  13p-dependency in the vesicle formation assay was 
generated by depleting Secl3p from membrane and cytosol 
fractions. Membrane-bound Secl3p was extracted by treat- 
ing membranes with 2.5 M urea. Urea extraction of micro- 
somes removed Secl 3p more efficiently than shown in Fig. 
4  for extraction of crude cell lysates. Secl3p was removed 
from the cytosol by affinity depletion of Sect3p-DHFR, as 
described above.  To provide all cytosolic proteins except 
Secl 3p, we pooled the MTX-agarose KC1 eluate, enriched in 
Sec23p and Sarlp,  with the MTX-agarose flow-through to 
serve as the Secl3p-depleted cytosol. We later found that the 
KC1 eluate could be replaced by a Sec23p-Sec24p complex- 
enriched fraction (high salt DEAE eluate; see Methods) and 
purified Sarlp. 
When Secl3p depleted membranes were combined with 
Secl 3p-depleted MTX-agarose flow-through and KCI eluate 
fractions,  vesicle release efficiency was only 20%  of the 
efficiency  of a complete cytosol fraction (Fig. 6, bar 2). This 
level of  efficiency  was about twice the background level mea- 
sured in a reaction incubated without cytosol. Activity was 
restored  synergistically to  the combined Secl3p-depleted 
flow-through and KC1 eluate fractions by adding 50 #g ofun- 
fractionated cytosol (Fig. 6, bar 3). This same amount of un- 
fractionated cytosol alone stimulated minimal vesicle re- 
lease  (Fig.  6,  bar  4).  A  Secl3p-enriched  fraction  was 
produced by precipitation of wild-type cytosol with 30% 
ammonium sulfate, which precipitates about 5 % of  cytosolic 
proteins, including all of the Secl 3p immunoreactivity. Ad- 
dition of 10 #g of this enriched fraction restored vesicle for- 
mation with a  higher specific activity than unfractionated 
cytosol (Fig. 6, bar 5). The reduction in activity of the MTX 
flow-through and KC1 wash fractions was due to the removal 
of Secl3p-DHFR,  because  comparable  flow-through and 
KCI eluate fractions derived from MTX-agarose chromatog- 
raphy of  wild-type cytosol were not defective (Fig. 6, bar 7). 
Unfractionated cytosol derived from RSY742  (expressing 
Secl3p-DHFR)  was as  active as wild-type cytosol in the 
vesicle release assay (Fig. 6, bar/). 
Additional controls showed that removal of Secl3p from 
both membrane and cytosol fractions was necessary to op- 
timize the assay. Extracted membranes combined with un- 
fractionated cytosol containing Secl 3p supported vesicle re- 
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Figure 6. Vesicle release in vitro is deficient in a Secl3p-depleted 
reaction and restored by cytosolic fractions containing Secl3p. Ves- 
icle release was measured as protease-protected pro-c~ factor re- 
leased into the MSS, relative  to total translocated  pro-c~ factor. Ves- 
icle release is indicated as a function of the efficiency  of a reaction 
combining complete wild-type cytosol with urea-extracted micro- 
somes (the absolute efficiency  of  this reaction was 25-30%). Using 
this complete reaction as a standard, vesicle formation efficiency 
values from different reactions were Ix)oled and averaged. Error 
bars represent the standard deviation within these averaged values. 
Background levels in the assay, measured as a no cytosol reaction, 
were typically 5% of the complete reaction. (1) Unfractionated 
RSY742 (expressing  Secl3p-DHFR) cytosol (n = 2); (2) combined 
RSY742 flow-through  and KC1 eluate from MTX-agarose chroma- 
tography, depleted of Secl3p-DHFR (n = 8); (3) addition of 50/~g 
complete cytosol to RSY742 combined flow-through  and KCI elu- 
ate (n ffi 7); (4) 50 t~g complete cytosol alone (n ffi 8); (5) addition 
of 10 ~g Seel3p-enriched 30 % (NI-h)2SO4 precipitate of wild-type 
cytosol to RSY742 combined flow-through  and KC1 eluate (n = 5); 
(6)  10 tzg 30%  (NI-I4)2SO4 precipitate alone (n  =  2); (7) com- 
bined flow-through  and KCl eluate from wild-type cytosol applied 
to MTX-agarose (n =  6). 
lease  in  vitro  with  the  same  efficiency as  unextracted 
membranes (not shown). Urea extraction of membranes re- 
duced background twofold in the presence of Secl3p de- 
pleted cytosol and rendered the vesicle formation assay more 
dependent on the addition of cytosolic Secl3p, as compared 
to unextracted membranes. 
Secl3p Fractionates as a High Molecular 
Weight Complex 
The  position  at  which  Secl3p  eluted  from gel  filtration 
columns suggested that Secl 3p participates in a high molecu- 
lar weight protein complex. Fractionation of wild-type cyto- 
sol by gel filtration, followed  by immunoblot analysis showed 
that Secl3p eluted at the position expected for a protein of 
about 700 kD (Fig. 7 a). Depending on the cytosol prepara- 
tion, a much smaller signal of immunoreactivity was usually 
detected at the position expected for a monomeric form of 
Secl3p. 
Results of fractionation of cytosol prepared  from cells 
overexpressing Secl3p were consistent with the hypothesis 
that Secl3p is assembled into a large protein complex. Ex- 
pression of SEC13 by a  multicopy plasmid in a  wild-type 
strain background yielded a nearly 40-fold increase in the 
level of Secl3p. Gel filtration of cytosol prepared from this 
strain (RSYS12) showed that the amount of Secl3p complex 
form was about the same as in wild-type cytosol (Fig. 7 b; 
note the difference in scale of arbitrary immunoreactivity 
units in Fig. 7, a and b) and that the majority of  overproduced 
Secl3p eluted in the position expected of a monomer (Fig. 
7 b). This result suggested that the assembly of Secl 3p into 
a larger complex form is limited by a factor distinct from 
Secl3p. 
The activity of gel filtration column fractions in the vesicle 
formation assay suggested that the Secl 3p complex and not 
the small, probably monomeric form, is the active species. 
Gel filtration fractions of wild type and Secl 3p overproducer 
cytosol were assayed and the peak of activity in both coin- 
cided with the large complex form of Secl3p (fractions 24 
and 25; see Fig. 7 a). Vesicle formation activity was not de- 
tected for the low molecular weight form of Secl 3p, even in 
cytosol prepared  from the Secl3p overproducer strain,  in 
which monomeric Secl3p is much more abundant than nor- 
mal (Fig. 7 b). 
Discussion 
Genetic and morphological data indicate that the sec13 mu- 
tant defect in secretion is imposed in a step before or concur- 
rent with the release of mature transport vesicles from the 
endoplasmic reticulurn membrane (21, 33).  In an effort to 
understand the biochemical function of Secl 3p in the molec- 
ular processes contributing to vesicle assembly, maturation 
and release, we have characterized the SEC13 gene product 
and developed a Secl3p-dependent in vitro reaction recon- 
stituting vesicle formation and release from the ER. In this 
paper, we report that SEC13 encodes a 33-kD protein con- 
taining a series of internal repeated sequence motifs with ho- 
mology to a functionally  divergent group of  proteins, includ- 
ing/3-transducin, that also contain this repeat. Secl3p is a 
cytosolic protein  that  associates peripherally  with  mem- 
branes. Cytosolic Secl 3p participates in a large protein com- 
plex that stimulates vesicle release from the ER in vitro. 
The identification of a  known peptide motif in the  se- 
quence of SEC13 may provide a clue to SEC13 function. In 
fact, the repeat structure appears to contribute to the role of 
SEC13 function in protein transport because we find that the 
secretion defective mutations alter residues that are con- 
served in this motif. The repeated sequence element is rec- 
ognized by a regular spacing between a histidine, an aspar- 
tate, and a tryptophan residue within a repeat unit of ,~40 
amino acid residues and was first seen in the 15 subunit of 
transducin (12). Approximately 10 other positions within the 
repeat are conserved to the extent that they are occupied by 
any one of a  number of chemically similar amino acids. 
More than 10 proteins that contain this repeated motif have 
now been recognized (reviewed in refs.  7 and 10).  These 
repeat-containing  proteins  are  involved  in  diverse  cell 
processes including transcriptional regulation (TUP/), RNA 
processing (  PRP4 and PRP17)  , cell cycle progression (  CDC4 
and CDC20), and growth regulation (G protein/3 subunits 
and MSII). Although SEC13 and the/3 subunit of transducin 
are  composed  almost entirely of the  repeated  segments, 
other proteins such as CDC4 and PRP4 contain additional 
sequences that could impart novel functions beyond those at- 
tributable to the repeat motif. 
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Figure 7. Secl3p fractionates as a high molecular weight complex. Fractions enriched in the complex are active in the Seel3p-dependent 
in vitro assay for vesicle release. Cytosol was prepared from (a) wild type (RSY607) or (b) RSYS12 (expressing $EC13 on a multicopy 
plasmid) cells and applied to a Superose 6 gel filtration column. Vo, Vi, and elution positions of protein standards (in kD) are indicated 
by arrows in a (669 kD, thyrogtobutin; 440 kD, ferritin, 158 kD, aldolase). Fractions were assayed for total protein and Sec13p distribution. 
Secl3p was detected by immunoblot analysis and quantified by t~SI-protein A and densitometry. Alternating fractions from the included 
volume of the column were assayed for activity by combining either (a) 25/~g protein (RSY607) or (b) 10/~1 (10-15/~g protein; RSY812) 
with Sec13p-depleted MTX agarose flow-through, a high-salt DEAE eluate, and purified Sarlp, as described in the text. The efficiency 
of vesicle release is expressed as the ratio of protease-protected 35S-pro-a factor rel~sed to a medium speed supernatant fraction, relative 
to total translocated pro-a factor. The last two bars in each plot represent (1) complete cytosol reaction and (2) Secl3p-depleted cytosol 
alone. All points are in duplicate; error bars represent standard deviation. 
What does the repeated motif say about Secl3p function? 
One possibility is that Secl 3p is a component of a heterotri- 
merit G protein that acts in protein transport.  As yet there 
is no direct evidence of a role for trimeric G proteins in yeast 
protein transport from the ER, although an involvement of 
trimeric G proteins in protein transport in the mammalian 
Golgi apparatus has been suggested on the basis of inhibition 
by AIF-, stimulation by excess B3' subunits and stimulation 
of transport by overexpression of Go in vivo (4, 24, 50). The 
subunit composition of most of the other repeat-containing 
proteins is not known, and the presence of repeats per se can- 
not be taken as strong evidence for a functional similarity to 
the G protein ~ subunit. A second possibility is that proteins 
that contain the peptide motif could have similar structures; 
the motif could define an dement of folded structure. In this 
case, the conserved hydrophobic positions could define buried 
residues that stabilize a particular polypeptide fold, or that 
interact with membranes or hydrophobic domains Of other 
proteins.  The  significance  of these  repeats  may  become 
clearer as we learn more about the proteins that associate 
with members of this family. 
A direct role for Secl3p in vesicle formation from the ER, 
predicted  by  the  phenotype  of sec13  mutants,  has  been 
confirmed biochemically using an in vitro assay that recon- 
stitutes vesicle formation and release. Cell-free transport as- 
says using membranes and cytosol prepared from secl3 mu- 
tants failed to reproduce a temperature-sensitive transport 
defect. Instead, we devised a Sec13p-dependant assay using 
membrane and cytosolic fractions that had been depleted of 
endogenous Sec13p.  When such depleted fractions are re- 
combined, vesicle formation becomes dependent on addition 
of cytosolic Secl3p, as demonstrated by the coincidence of 
immunoreactive and functional Secl3p fractionated by selec- 
tive ammonium sulfate precipitation and gel filtration. 
Although Secl3p is a 33-kD protein, the majority of eyto- 
solic Secl3p elutes from a gel filtration column at the posi- 
tion expected for a protein of nearly 700 ltD. Column frac- 
tions  containing  this  complex  restore  vesicle  formation 
activity  to  the  Sec13p=depleted  assay.  Overexpression  of 
SEC13 resulted in abundant overproduction of an apparently 
monomeric form of Secl3p that does not stimulate vesicle 
formation. Overproduction of the monomeric form suggests 
that another subunit of the Secl3p complex is in limited sup- 
ply when Secl3p is overproduced. Immunoblotting with an- 
tibodies against other known See proteins required for vesi- 
cle formation  (Sec23p,  Sec24p,  Sec21p,  Secl6p) failed to 
Pryer et ai. Secl3p  Complex in Vesicle Formation  873 detect an immunoreactive  species that co-fractionated  with 
the Secl3p complex, suggesting that other member(s) of the 
Secl  3p complex are proteins not previously identified by mu- 
tant  selections.  We  are  currently  purifying  the  Secl3p- 
containing  complex and characterizing  the other member(s) 
of the complex. 
Secl3p partitions  between a  sedimentable,  membrane- 
bound form and a soluble, cytosolic pool. The sedimentable 
portion of Secl3p is peripherally associated with the mem- 
brane and can be extracted either by detergent solubilization 
of the membrane or by treatment with agents that disrupt 
protein-protein interactions  (e.g., urea or sal0. While the 
cell fractionation  experiments  cannot determine the precise 
membrane compartment that binds Secl3p, the requirement 
for Secl3p in vesicle formation from the ER suggests that 
See13p is associated at least with the ER membrane. Seel3p 
may localize to other cellular membrane compartments as 
well. Because the addition  of cytosolic Secl3p is sufficient 
to allow vesicle formation in the Secl3p-depleted reaction, 
either the cytosolic form is active, or the cytosolic form is 
recruited to the membrane and there stimulates  vesicle for- 
mation or release. Regulated recruitment of cytosolic Secl3p 
to sites of active vesicle formation  would permit the cell to 
regulate budding temporally and spatially. 
The Secl3p complex is similar in some respects to the See 
23p-Sec24p complex, which is also required for vesicle for- 
marion from the ER (16, t7). Sec23p was identified geneti- 
cally in the original selection for secretion mutants (34) and 
Sec24p was identified later upon purification of  the complex. 
Sec23p and Sec24p are both required for protein export from 
the ER in vivo and in vitro.  Both the Sec23p-Sec24p com- 
plex and the Secl3p complex partition  between membrane 
and cytosol forms, the complex form predominating  in wild- 
type cytosol.  Overexpression  of either  SEC13  or SEC23 
results in overproduction  of the monomeric form alone (17). 
Unlike Secl3p, the monomeric form of Sec23p is functional 
in a biochemical complementation assay. 
sec13  exhibits  synthetic  lethal  interactions  with sec23, 
sec12, and sec16 (21), in which a double mutant is defective 
for growth and secretion at a lower temperature than either 
single mutant alone.  Such genetic interaction  suggests that 
proteins function in the same step or pathway, but does not 
necessarily imply direct protein-protein interaction.  Thus 
the functions of the proteins encoded by genes that interact 
with SEC13 may provide a clue to the function  of Secl3p. 
Sec23p recently was found to act as a GTPase-activating pro- 
tein, stimulating  GTP hydrolysis by Sarlp,  a Ras-like small 
GTPase required for vesicle budding from the ER (6, 28, 
35). GTP hydrolysis by purified Sarlp in vitro is very slow, 
but the  addition  of purified  Sec23p monomer  stimulates 
Sarlp GTPase activity 10-15-fold  (53).  GTP hydrolysis  is 
further stimulated by the cytosolic domain of Secl2p, an in- 
tegral membrane protein of the ER. Secl2p acts to catalyze 
GDP release, facilitating its replacement by GTP (Barlowe, 
C., and R. Schekman, unpublished results).  Sec13p might 
serve as either  an upstream regulatory factor or a down- 
stream effector of this system. 
Vesicle formation and release from the ER membrane re- 
quires the concerted action of a number of proteins.  As a 
membrane-associated protein acting at the cytosolic face of 
the ER membrane, See13p might participate in vesicle bud- 
ding at a number of different steps. Secl3p may act to specify 
sites of active, budding-competent  ER membrane.  Alterna- 
tively, Secl3p might contribute to the formation of a vesicle 
coat, either as a structural component of the coat or an as- 
sembly/disassembly factor.  Finally, Secl3p could stimulate 
the ER membrane deformation needed to form a curved vesi- 
cle, or aid in severing a newly-formed vesicle from the ER 
membrane.  Reconstitution  of vesicle biogenesis  in  vitro 
using fully resolved cytosolic and peripheral membrane fac- 
tors will address the exact roles of Secl3p and other cytosolic 
and peripheral membrane proteins in vesicle formation  and 
release. 
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